Biography of Brenda Cooperstone
Last update: 12 days agoCareer
Brenda was Senior Vice President and Chief Development Officer for rare disease in Global Product Development for Pfizer. Brenda Cooperstone joined Senti Biosciences in 2023.
Brenda Cooperstone is currently- Director at Gandeeva Therapeutics - View - Gandeeva Therapeutics org chart
- Director at Lexeo Therapeutics - View - Lexeo Therapeutics org chart
- Director at Senti Biosciences - View - Senti Biosciences org chart
Create your alert
to follow the career of Brenda Cooperstone.
Education
In 1988, Brenda Cooperstone completed a Doctor of Medicine at McGill University.
They have also studied at McGill University :
Find more alumni from McGill University
More about Brenda Cooperstone
Selected links
Do you need to know more about Brenda Cooperstone? More results.
Participate
Social media
- Brenda Cooperstone on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Brenda Cooperstone
The colleagues of Brenda Cooperstone
Company Colleagues
- At Gandeeva Therapeutics, Brenda Cooperstone has 8 colleagues including Sriram Subramaniam (CEO), Josh Wolfe (Director)…
- At Lexeo Therapeutics, Brenda Cooperstone has 17 colleagues including Nolan Townsend (CEO & Director), Mette Kirstine Agger (Director)…
- At Senti Biosciences, Brenda Cooperstone has 13 colleagues including Tim Lu (CEO & Director), James Collins (Director)…
Industry Colleagues
- In the Biotechnology industry, Brenda Cooperstone has 30,251 colleagues in 2,282 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Brenda Cooperstone.
Get in Touch
and ask for Brenda Cooperstone.
